Palatin Technologies
PTN
#10924
Rank
A$14.1 M
Marketcap
A$7.92
Share price
-0.74%
Change (1 day)
-59.60%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -A$12.14 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$13.18 Million. In 2025 the company made an earning of -A$14.3 Million, an increase over its 2024 earnings that were of -A$40.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$12.14 Million-15.11%
2025 -A$14.3 Million-64.29%
2024 -A$40.03 Million-16.9%
2023 -A$48.18 Million5.99%
2022 -A$45.46 Million-13.7%
2021 -A$52.67 Million33.25%
2020 -A$39.53 Million-172.11%
2019 A$54.8 M2352.33%
2018 A$2.23 M-94.13%
2017 A$38.08 M-154.92%
2016 -A$69.34 Million3.67%
2015 -A$66.89 Million878%
2014 -A$6.84 Million-72.64%
2013 -A$25 Million-33.11%
2012 -A$37.37 Million77.71%
2011 -A$21.03 Million
2003 -A$35.61 Million29.93%
2002 -A$27.41 Million36.18%
2001 -A$20.13 Million
1999 -A$16.71 Million6.04%
1998 -A$15.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.81 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$22.42 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.28 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.98 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$90.51 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.23 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$43.82 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$82.11 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA